Curis Inc - Company Profile
Powered by 
All the sales intelligence you need on Curis Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Curis Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Curis Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Curis Inc (Curis) specializes in developing innovative cancer treatments. It excels with strong intellectual property, research and development activities and its lead product candidate, emavusertib. However, the company’s history of operating losses poses a concern. Growth opportunities are supported by the market potential for acute myeloid leukemia (AML), orphan drug designation, and a promising product pipeline. However, the company faces significant threats from intense competition, stringent regulations and rapid technological advancements that can impact its operations and market position.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer